Texas

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.

The lessons learned from the global pandemic are expected to translate to existing and emerging therapeutic areas - particularly oncology; more efficient regulatory-industry relationships; mRNA is a word we will continue to hear a lot about; and home health care is here to stay.

Regulating the activity of the protein called NF-kappa B-inducing kinase (NIK) is emerging as a new and potentially important way to enhance certain immuno-oncology therapies.

Morrisville, North Carolina, has reason to hope that it may be the beneficiary of Fujifilm’s next major investment, a $2 Billion USD large-scale cell culture manufacturing site which the company said will be located near one of its current facilities.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.

“The future will be overrun by an army of new choices and changes in attitudes towards one’s own health. That creates a whole new area for bioscience and health, and for investing,” Mike Edelhart, managing partner, Social Starts & Joyance Partners said.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Many drug makers are investing in new science and hope to develop new therapeutics that address autoimmune disease. BioSpace has captured some key efforts.